PAULA DORN: Open Payments
NPI 1144863689 · NEWARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,060 in 145 payments from 14 companies in 2025. Trend: 2023 $1,221 · 2024 $2,461 · 2025 $3,060
Food & beverage: $3,009Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $766 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $489 |
| Janssen Biotech, Inc. | 17 | $429 |
| Phathom Pharmaceuticals, Inc. | 19 | $348 |
| Ardelyx, Inc. | 10 | $219 |
| PFIZER INC. | 9 | $181 |
| Madrigal Pharmaceuticals | 5 | $144 |
| Lilly USA, LLC | 7 | $115 |
| GENZYME CORPORATION | 3 | $93 |
| Gilead Sciences, Inc. | 5 | $88 |
Products named: TREMFYA, ENTYVIO, VOQUEZNA, RINVOQ, SKYRIZI, IBSRELA, DUPIXENT, REZDIFFRA.
Industry payments across NY — which companies pay providers there.
